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Abstract The structural features of binding sites for volatile
anesthetics are examined by performing a molecular dynamics
simulation study of the synthetic four-K-helix bundles (AK2)2,
which are formed by association of two 62-residue di-K-helical
peptides. The peptide bundle (AK2)2 was designed by Johansson
et al. [Biochemistry 37 (1998) 1421^1429] and was shown
experimentally to have a high affinity for the binding of the
anesthetic halothane (CF3CBrClH) in a hydrophobic cavity.
Since (AK2)2 can exhibit either the anti or syn topologies, the two
distinct bundles are simulated both in the presence and in the
absence of halothane. Nanosecond length molecular dynamics
trajectories were generated for each system at room temperature
(T = 298 K). The structural and dynamic effects of the inclusion
of halothane are compared, illustrating that the structures are
stable over the course of the simulation; that the (AK2)2 bundles
have suitable pockets that can accommodate halothane; that the
halothane remains in the designed hydrophobic cavity in close
proximity to the Trp residues with a preferred orientation; and
that the dimensions of the peptide are perturbed by the inclusion
of an anesthetic molecule.
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1. Introduction
The distinct in vivo molecular targets for inhaled general
anesthetic action remain unknown despite decades of re-
search. Ambiguity persists in the relative roles of lipids and
proteins in the mechanism of anesthesia, and in the existence
of speci¢c versus non-speci¢c binding sites for inhaled anes-
thetics [1^3]. Quantitative considerations have tilted the focus
in recent years to membrane-bound proteins, in particular to
trans-membrane ion channels [4^8]. Current interest lies in the
understanding of the properties and structural features of
anesthetic binding sites in proteins. Numerous spectroscopic
studies have illustrated that speci¢c, discrete sites exist in both
water-soluble proteins and membrane-bound proteins, where
anesthetics may bind [9^17]. These sites are predominately
hydrophobic in character but also have hydrophilic, polar
components [18^20]. Uncertainty still exists in the exact rela-
tion between critical amino acids and the potential anesthetic
binding sites [3]. In the reconstituted GABAA receptor, for
example, a number of amino acids in the sequence were sug-
gested to control the gating response observed in the presence
of anesthetics [21].
The complex nature of membrane-bound proteins moti-
vated a novel approach to study their properties by using
synthetic peptides with known amino acid sequences, which
are representative of the lipid-spanning domain of native
structures [22,23]. Such synthetic designed peptides may ex-
hibit speci¢c binding for anesthetics [24,25]. More recently
Johansson et al. have designed a synthetic peptide, (AK2),
which in dimeric form speci¢cally binds the inhaled anesthetic
halothane (CF3CBrClH) with high a⁄nity [26]. The dimer
(AK2)2 consists of two 62-residue segments, each containing
two 27-residue K-helical stretches connected by an eight-resi-
due Gly loop linker. The two monomers associate into a
water-soluble four-K-helix bundle with a hydrophobic core
containing two Trp residues. The binding of halothane to
the hydrophobic interior of the (AK2)2 bundle is inferred ex-
perimentally from the quenching of the Trp £uorescence spec-
trum. Since £uorescence quenching by heavy atoms occurs
over distances of less than 3^5 Aî [27,28], the halothane mol-
ecule is likely to be located in close proximity to one (or both)
of the core Trp residues.
Two possible topologies exist for the dimer (AK2)2, either
anti [29,30] or syn [31,32]. When a spin label is attached to the
Cys residues within the hydrophobic core of (AK2)2, the anti
topology is predominant (s 99%) in water [26]. However,
since the size of the spin label is large, it remains open to
question whether the anti topology is favored for the (AK2)2
bundle without the spin label.
A description of the interactions between halothane and the
four-K-helix structure, and of the relative orientation of the
anesthetic molecule with respect to speci¢c residues in the
hydrophobic core cannot be obtained from experimental stud-
ies such as [26]. The favorable interactions between halothane
and the interior of the (AK2)2 suggest that suitable hydropho-
bic interior pockets for the anesthetic have been achieved by
the peptide design. Molecular dynamics (MD) simulations can
examine structure stability, interactions and molecular mo-
tions that occur on nanosecond time scales. The use of MD
simulations to probe the structural and dynamic properties of
biological molecules is well established and the results ob-
tained can be used to complement experimental ¢ndings [33].
Our goal in this paper is to test the proposed design for
(AK2)2 by implementing MD simulation techniques. We
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Fig. 1. Sequence of the AK2, the synthetic di-K-helical peptide de-
signed to have hydrophobic residues occupying the heptad a and d
positions (shown in bold italic) inside the core of the water soluble
four-K-helix bundle (AK2)2 [26].
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Fig. 2. Initial con¢gurations of the (AK2)2 four-K-helix bundles used in the simulations, in (a) anti and (b) syn topologies, both in the presence
of halothane. The four helices are shown in light blue ribbon rendering with the amino acid side chains in sticks, the interior Trp residues
shown in dark blue, the carbon atoms of the halothane molecule are in gray, its £uorine atoms in yellow, bromine atom in orange and chlorine
in green.
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present the results of MD simulation studies of the four-K-
helix bundle (AK2)2 in both the anti and syn topologies, each
in the presence and absence of a single halothane molecule.
Speci¢cally, we examine the stability of the designed (AK2)2
structures and the ability of the associated bundles to yield
suitable hydrophobic cores, which can accommodate halo-
thane in close proximity to the Trp residues. We concentrate
on structural consequences and modi¢cations to the (AK2)2
bundles upon addition of the anesthetic halothane, the dy-
namics and relative orientation of the halothane in the pro-
posed cavities.
2. Simulation system and methodology
The initial coordinates for the di-K-helical monomer AK2
were obtained using InsightII software (Molecular Simulation
Fig. 3. Average con¢gurations for the anti topology of the synthetic (AK2)2 four-K-helix peptide bundle (AK2)2 obtained over the last 500 ps of
the simulation, in the absence (a) and in the presence (b) of halothane. See Fig. 2 for color code.
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Inc., San Diego, CA, Version 97.2) by constructing ideal
right-handed K-helices using the amino acid sequence given
in [26], see also Fig. 1. The four-K-helix bundle was formed
by placing two of these monomers together in either the anti
or syn topology. Care was taken to ensure that none of the
side chain atoms in the structure were overlapping, but the
monomers were placed close enough so that interactions could
easily occur between residues of the two monomers. The hy-
drophobic side chains were thus initially within the core of the
four-K-helix structure. When the anesthetic was included in
Fig. 4. Average con¢gurations for the syn topology of the synthetic (AK2)2 four-K-helix peptide bundle (AK2)2 obtained over the last 500 ps of
the simulation, in the absence (a) and in the presence (b) of halothane. See Fig. 2 for color code.
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the system, a single halothane molecule (also constructed us-
ing InsightII) was placed in a cavity within the hydrophobic
core of the synthetic peptide. No anesthetic and the protein
atoms were less than 1.6 Aî apart, see Fig. 2. The halothane
molecule was placed in an orientation such that its carbon-
carbon axis was parallel to the long axis of the four helices,
with the di-halogenated carbon atom closest to the Trp resi-
dues in the core. In the anti topology the two hydrophobic
cavities above and below the Trp residues are equivalent, but
in the case of the syn topology two distinct locations for the
halothane exist ; in our simulation of the syn topology we
initially place the anesthetic molecule in the cavity between
the two Trp residues and the Gly loop region.
Minimizations of each structure were performed using a
steepest descent algorithm in CHARMM [34] with the helix
backbone atoms initially constrained and then with all the
atoms free to move. All unfavorable interactions within these
initial structures were thus removed. The potential energy
function for the dynamics of each of the four bundles was
then constructed using the AMBER-95 parameter set [35^
37], where the empirical form of the energy expression is given
as a sum of inter- and intra-molecular interactions. The inter-
molecular portion consists of van der Waals interactions
which are repulsive at very short distances and attractive at
larger separations, and an electrostatic contribution, which
accounts for the interactions between charged species. The
intra-molecular component contains contributions due to
bond stretching, bond-angle bending and bond torsions. For
halothane we use interaction parameters from [38]. The stand-
ard Lorenz-Berthelot combining rules were used to calculate
the cross interactions between the peptide and halothane.
The extended system simulation method of the PINY-MD
computational package [39,40] was used to obtain constant
NVT MD trajectories for the four synthetic peptide systems.
In this initial study no explicit solvent is used. The standard
periodic boundary conditions and minimum image conven-
tions are incorporated into this approach, and Nose¤-Hoover
thermostat chains of length m = 2 maintain a constant system
temperature of T = 298 K. Electrostatic interactions are calcu-
lated using the particle-mesh Ewald technique [41]. All bonds
to hydrogen atoms were constrained to their equilibrium val-
ues during the simulation using the SHAKE and RATTLE
algorithms. The unit cell of the simulation consisted of a
rectangular box of size 40 AîU40 AîU60 Aî , where the long
axis of the four-K-helix structure was placed parallel to the
long box axis.
Four individual simulations of the synthetic four-K-helix
bundles were performed; one with the AK2 peptide monomers
in an anti topology; another with the monomers in a syn
topology; and two more with the anti and syn topologies in
the presence of halothane. Each system was equilibrated in
three stages: 10 ps at T = 1 K, 40 ps at T = 150 K and 50 ps
at T = 298 K. A 1 ns trajectory was then generated for each of
the four structures using a time-step of 0.5 fs at T = 298 K.
3. Results and discussion
At the end of 1 ns of simulation each of the four systems
maintain an overall four-K-helical structure with the hydro-
phobic side chains in the amino acid sequence contained with-
in the core. Some unraveling of the helices at the C and N
terminals, and close to the Gly loop region is observed, to-
gether with a signi¢cant amount of bending and twisting (see
Figs. 3 and 4). Following an initial period of V200 ps the
inter-helical distances reach their equilibrium values around
which only small £uctuations are observed. For example, in
the case of the (AK2)2 peptide in the anti topology the four
inter-helical distances are 10.71 þ 0.84 Aî , 10.34 þ 0.81 Aî ,
11.65 þ 0.92 Aî and 11.05 þ 0.87 Aî , respectively.
Insight into the overall structure is obtained via a calcula-
tion of the inertia tensor of the bundles. The two components
of the inertia tensor in the plane perpendicular to the long axis
of the helices are decreased in both the anti and syn topologies
when halothane is present in the hydrophobic core, indicating
that the structures are more swollen in the presence of anes-
thetic. Conversely, the component of the inertia tensor paral-
lel to the long axis of the helices increases upon addition of
halothane, which corresponds to a decrease in the overall
length of the four-K-helices. This e¡ect is most apparent for
the anti topology. The deformation of the structure due to the
presence of halothane is illustrated further by monitoring the
average lengths of the four-K-helices during the simulation. In
both the anti and syn topologies addition of halothane is
found to decrease this average end-to-end helix distance,
which is manifest even after the CHARMM minimization.
The di¡erence between the results obtained for the systems
with and without the anesthetic is again more pronounced
in the anti topology of the (AK2)2 four-helix bundle.
In addition to the overall structural modi¢cations to the
four-K-helix bundle due to the anesthetic, other interesting
e¡ects can be observed via a more detailed study of the dy-
namic behavior of the halothane molecule. During the simu-
lations, for both the anti and syn topologies, the halothane
molecule is con¢ned into the small region within the hydro-
phobic core of the peptide structure where it was initially
placed. The absence of any large-scale migration of the anes-
thetic is to be expected due to the relatively short (nanosec-
ond) time scale of the simulation. However, a signi¢cant
amount of rotational and translational motion of halothane
is observed inside the cavity, the net e¡ect of which is motion
towards the Trp residues. In particular, the distance between
the two Trp residues within the hydrophobic core is signi¢-
cantly increased in the presence of halothane for the anti top-
ology. The separation of these two aromatic residues is not
a¡ected by the addition of anesthetic in the syn topology.
Halothane appears to have a favorable interaction with one
Trp in the core of the anti topology, which draws this residue
away from the vicinity of the other Trp side-chain. The lack
of a similar e¡ect in the syn topology could be a result of a
di¡erence in structure of the hydrophobic core region close to
the Trp residues as compared to the corresponding location in
the the anti oriented four-K-helix bundle.
Close examination of the relative orientation of the halo-
thane molecule during the simulations of both the anti and
syn topologies show that the di-halogenated carbon atom is
found closest to the Trp residues. Despite having been placed
in this orientation initially, the halothane molecules do rotate
completely during the simulation, so that the tri-£uorinated
carbon is closest to the Trp residues, see Fig. 5. However, the
halothane molecules return very rapidly to their preferred
orientation. This corresponds to the experimental observa-
tions of the pronounced quenching of the Trp £uorescence
spectrum, which requires that the halothane halogen atoms
and the Trp side chains are in close proximity.
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4. Conclusions
A MD simulation study has been performed at T = 298 K
for a synthetic four-K-helix bundle (AK2)2 in two di¡erent
topologies, both in the presence and in the absence of the
volatile anesthetic halothane. Overall, the helical character
and the position of the hydrophobic residues within the cavity
of peptide bundle are all maintained on a nanosecond time
scale. Occupation of the hydrophobic cavity by halothane
leads to structural changes in the four-K-helix bundles, most
signi¢cantly in the anti topology. Analysis of the motion of
the halothane molecule within the cavity in the protein scaf-
fold illustrates that the halothane exhibits a preferred orienta-
tion with respect to the Trp residues in the core, with the di-
halogenated carbon closer to the core Trp residues than the
tri-£uorinated carbon. This is consistent with the £uorescence
quenching observed in [26]. The ability of this gas-phase sim-
ulation study, for the same peptide system, to give results
which are in line with experimental ¢ndings is most gratifying.
More extensive simulations, where the four-K-helix bundle is
in aqueous solution are currently being performed, and pre-
liminary results indicate that water molecules are completely
excluded from the hydrophobic core of the peptide sca¡old
(both in the presence and absence of halothane). Thus, the
absence of explicit solvent in the present work does not a¡ect
the dynamic features of the anesthetic molecule.
The use of a designed synthetic peptide to study the nature
of protein-anesthetic interactions is a novel approach where
experimental and simulation methods can be used in parallel
to obtain a systematic analysis of the governing factors. Such
studies are only able to provide insight into the structural
features of the binding of halothane to the hydrophobic inte-
rior of this speci¢c model. However, the interactions of anes-
thetics with hydrophobic pockets is likely to be only one of
the many possible ways in which protein structure is modi¢ed
in vivo.
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